Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Uniqure N.V. (QURE)

Uniqure N.V. (QURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Uniqure N.V. PAASHEUVELWEG 25 AMSTERDAM P7 1105 BP NLD

www.uniqure.com Employees: 209 P: 31-20-240-6000

Sector:

Medical

Description:

UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 1,395,341
Enterprise Value, $K 1,287,731
Shares Outstanding, K 62,292
Float, K 59,308
% Float 95.21%
Short Interest, K 11,997
Short Float 19.26%
Days to Cover 4.35
Short Volume Ratio 0.38
% of Insider Shareholders 4.79%
% of Institutional Shareholders 78.83%

Financials:

Annual Sales, $ 27,120 K
Annual Net Income, $ -239,560 K
Last Quarter Sales, $ 3,700 K
Last Quarter Net Income, $ -80,530 K
EBIT, $ -180,070 K
EBITDA, $ -167,430 K

Growth:

1-Year Return 45.81%
3-Year Return 5.46%
5-Year Return -36.74%
5-Year Revenue Growth 272.53%
5-Year Earnings Growth -58.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.38 on 11/10/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -4.39
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year -51.65%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

QURE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -373.73%
Return-on-Assets % -35.69%
Profit Margin % -883.33%
Debt/Equity 0.23
Price/Sales 76.98
Price/Cash Flow N/A
Price/Book 5.48
Book Value/Share 4.17
Interest Coverage -2.72
60-Month Beta 0.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar